Ambient air pollution and asthma exacerbations in children: An eight-city analysis

被引:152
作者
Schildcrout, Jonathan S.
Sheppard, Lianne
Lumley, Thomas
Slaughter, James C.
Koenig, Jane Q.
Shapiro, Gail G.
机构
[1] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA
[2] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Environm Protect Agcy, NW Res Ctr Particulate Air Pollut & Hlth, Seattle, WA 98195 USA
[4] Univ Washington, Sch Publ Hlth, Dept Environm Hlth, Seattle, WA 98195 USA
[5] Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA
[6] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA
关键词
air pollution; asthma; carbon monoxide; nitrogen dioxide; ozone; pediatrics; sulfur dioxide;
D O I
10.1093/aje/kwj225
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The authors investigated the relation between ambient concentrations of five of the Environmental Protection Agency's criteria pollutants and asthma exacerbations (daily symptoms and use of rescue inhalers) among 990 children in eight North American cities during the 22-month prerandomization phase (November 1993-September 1995) of the Childhood Asthma Management Program. Short-term effects of carbon monoxide, nitrogen dioxide, particulate matter less than 10 mu m in aerodynamic diameter (PM10), sulfur dioxide, and warm-season ozone were examined in both one-pollutant and two-pollutant models, using lags of up to 2 days. Lags in carbon monoxide and nitrogen dioxide were positively associated with both measures of asthma exacerbation, and the 3-day moving sum of sulfur dioxide levels was marginally related to asthma symptoms. PM10 and ozone were unrelated to exacerbations. The strongest effects tended to be seen with 2-day lags, where a 1-parts-per-million change in carbon monoxide and a 20-parts-per-billion change in nitrogen dioxide were associated with symptom odds ratios of 1.08 (95% confidence interval (CI): 1.02, 1.15) and 1.09 (95% CI: 1.03, 1.15), respectively, and with rate ratios for rescue inhaler use of 1.06 (95% CI: 1.01, 1.10) and 1.05 (95% CI: 1.01, 1.09), respectively. The authors believe that the observed carbon monoxide and nitrogen dioxide associations can probably be attributed to mobile-source emissions, though more research is required.
引用
收藏
页码:505 / 517
页数:13
相关论文
共 41 条
[1]   Trends in childhood asthma: Prevalence, health care utilization, and mortality [J].
Akinbami, LJ ;
Schoendorf, KC .
PEDIATRICS, 2002, 110 (02) :315-322
[2]  
[Anonymous], 2006, R LANG ENV STAT COMP
[3]  
Asher MI, 1998, EUR RESPIR J, V12, P315
[4]   The burden of asthma with specific reference to the United States [J].
Beasley, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (05) :S482-S489
[5]   Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema:: ISAAC [J].
Beasley, R ;
Keil, U ;
von Mutius, E ;
Pearce, N ;
Aït-Khaled, N ;
Anabwani, G ;
Anderson, HR ;
Asher, MI ;
Björkstéin, B ;
Burr, ML ;
Clayton, TO ;
Crane, J ;
Ellwood, P ;
Lai, CKW ;
Mallol, J ;
Martinez, FD ;
Mitchell, EA ;
Montefort, S ;
Robertson, CF ;
Shah, JR ;
Sibbald, B ;
Stewart, AW ;
Strachan, DP ;
Weiland, SK ;
Williams, HC .
LANCET, 1998, 351 (9111) :1225-1232
[6]   Health effects of air pollution [J].
Bernstein, JA ;
Alexis, N ;
Barnes, C ;
Bernstein, IL ;
Bernstein, JA ;
Nel, A ;
Peden, D ;
Diaz-Sanchez, D ;
Tarlo, SM ;
Williams, PB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (05) :1116-1123
[7]   Symptoms in pediatric asthmatics and air pollution: Differences in effects by symptom severity, anti-inflammatory medication use and particulate averaging time [J].
Delfino, RJ ;
Zeiger, RS ;
Seltzer, JM ;
Street, DH .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 (11) :751-761
[8]   Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores [J].
Delfino, RJ ;
Coate, BD ;
Zeiger, RS ;
Seltzer, JM ;
Street, DH ;
Koutrakis, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :633-641
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]  
DEY AN, 2005, VITAL HLTH STAT, V10, P1